A word from our CEO and Chairman
"Source BioScience is built on decades of trust from the healthcare and life science sectors. Working with our partners to deliver the best possible patient outcomes and research data is paramount in everything we do."
Jay LeCoque
CEO and Chairman
Jay LeCoque
Jay LeCoque is CEO of Source BioScience and Executive Chairman of SourceBio. He has over 25 years of senior management experience mainly focused on listed UK life sciences companies. Jay joined the Group in 2016 initially as Non-Executive Chairman and was appointed Executive Chairman in 2017. Jay was also an Executive Director of Bioquell plc from 2016 until its acquisition by ECOLAB in 2019. Prior to that, he was CEO of Celsis International plc from 2000 to 2009, and remained CEO following a public to private transaction in 2009 to form Celsis International Ltd until its acquisition in 2015. Jay gained an MBA from Northwestern University’s Kellogg Graduate School of Management in Chicago.
Amanda Barlow
Amanda Barlow has over 20 years’ experience leading Financial and Operational Teams across a range of industries ranging from Hospitality to Construction. She gained a BA(hons) in Accounting at the University of Derby and qualified as an FCMA shortly afterwards. Amanda joined the company in 2023 and brings with her a wealth of experience from several senior operational, strategic and financial leadership roles. She is a keen advocate of giving back to the community and has contributed locally as a School Governor, Rugby Club Secretary and regularly raises funds for charities close to her heart.
Nick Bills
Nick Bills has been a Biomedical Scientist for over 30 years working in the Armed Forces, NHS and Private Healthcare environments. He completed his BSc, Fellowship and MSc in Biomedical Science at The University of the West of England and Southampton University respectively. Nick has been in a senior leadership role for over 10 years and is responsible for our laboratory services to both our clients and the patient. Being Source LDPath’s Caldicott Guardian and CQC Registered Manager he is focussed on developing our state-of-the art laboratory and digital pathology offerings whilst ensuring the highest clinical standards are achieved.
Tom Burr, PhD, FRSB
Tom has more than 20 years’ experience in the commercial and academic lifesciences sectors which he uses to help drive the ongoing R&D, clinical service development and regulatory affairs activities across the business. A Fellow of the Royal Society of Biology, he obtained a PhD in Molecular Genetics before pursuing his post-doctoral research at Harvard Medical School and the University of Cambridge. Tom works closely with the Operational, Commercial and Quality teams to continually expand and improve our services, whilst retaining the high-quality, patient-focussed standards that customers require.
Richard Stevens
Richard Stevens has 30 years of experience within both academic and industry settings working for Biotech and Pharmaceutical companies in the field of molecular Biology and Genomics. Richard has gained over 20 years leadership experience during his career and has developed teams so they remain at the forefront of technology. He is also trained in operational excellence and lean sigma six practices, maintaining a strong focus on process efficiency, customer focus and quality. As Director of Genomics, Richard is responsible for both the commercial and operational delivery of our genomics portfolio to support the needs of our client and their research goals.
Klaudyna Johnstone
Klaudyna Johnstone has led commercial teams for over 10 years in both pharmaceuticals and the life sciences. She completed her BSc in Human Genetics at the University of Nottingham and MRes in Biomedicine at UCL. Klaudyna's focus is on bridging commercial success with life science and healthcare innovation, with a particular focus on digital pathology, genomics and precision medicine.
Marc Thomas
Marc is the former CEO of LDPath and a Fellow of the Institute of Chartered Accountants of England and Wales. He qualified with Stoy Hayward Chartered Accountants in London in 1991. Marc subsequently worked at Credit-Suisse for over 25 years in a number of finance related roles including reporting and finance system development.
Sanj Lallie
Sanj is the Commercial Director of Digital Pathology at Source LDPath. Sanj joined LDPath (recently acquired by Source BioScience to form Source LDPath) soon after graduating from Nottingham Business School with a degree in Business Information Systems, initially to provide technical support; has since established our NHS support service, the digital pathology network, and developed the overseas sister branches LDPath India and LDPath Dubai.
Scientific Advisory Board
Dr Alistair Robson
Dr Alistair Robson is a qualified general (FRCPath) and specialist dermatopathologist (DipRCPath) and was Consultant Dermatopathologist at St John’s Institute of Dermatology, St Thomas’ Hospital, London, for 14 years following a Clinical Lectureship at the University of Oxford.
Dr Robson has presented research and been an invited speaker both nationally and internationally. He reviews dermatopathology papers for several journals and has more than 100 articles published in peer-reviewed journals.
Dr Robson is also a visiting pathologist at the Lisbon Institute of Oncology in Portugal and the pathology lead for cutaneous lymphoma and continues to be an active member of the EORTC cutaneous lymphoma pathology working group.
Professor Ian Ellis
Professor Ian O. Ellis has been involved in the practice of pathology for forty years and has an international reputation in clinical and translational research in breast disease, particularly classification and molecular pathology of breast cancer and evaluation of prognostic factors. Author of over 750 peer reviewed scientific publications, chapters in medical textbooks and specialist textbooks in pathology and an experienced lecturer being a founder member of the faculty of the Nottingham Blamey International Breast Education Centre. His H Index is 103.
He is a Past President of the Pathological Society of Great Britain and Ireland. He has been Specialty Advisor to The Royal College of Pathologists, and is past Chairman of the UK National Co-ordinating Committee for Breast Pathology. He has acted as an advisor to the DoH, UICC, WHO and IARC. He is Medical Director of Source Bioscience.